Foamix Disappointing IPO Drops Share Price to $6

Israeli biomedical firm Foamix is moving ahead with its New York IPO, but has greatly reduced its expectations, dropping it’s per share asking price to only $6 from the previously expected $10 to $12 range. The More...

3 Israeli biomed cos fall sharply after Nasdaq IPOs

– BioBlast’s share lost 38% of its value, Macrocure 25%, and VBL Therapeutics 18%. –   The shares of three Israeli biomedical companies that completed their IPOs last Wednesday More...